These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 16540796

  • 1. Decreased peroxisome proliferator activated receptor alpha is associated with bile duct injury in cystic fibrosis transmembrane conductance regulator-/- mice.
    Pall H, Zaman MM, Andersson C, Freedman SD.
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):275-81. PubMed ID: 16540796
    [Abstract] [Full Text] [Related]

  • 2. Induction of colitis in cftr-/- mice results in bile duct injury.
    Blanco PG, Zaman MM, Junaidi O, Sheth S, Yantiss RK, Nasser IA, Freedman SD.
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G491-6. PubMed ID: 15064232
    [Abstract] [Full Text] [Related]

  • 3. Decreased expression of peroxisome proliferator activated receptor gamma in cftr-/- mice.
    Ollero M, Junaidi O, Zaman MM, Tzameli I, Ferrando AA, Andersson C, Blanco PG, Bialecki E, Freedman SD.
    J Cell Physiol; 2004 Aug; 200(2):235-44. PubMed ID: 15174093
    [Abstract] [Full Text] [Related]

  • 4. Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury.
    Stalvey MS, Muller C, Schatz DA, Wasserfall CH, Campbell-Thompson ML, Theriaque DW, Flotte TR, Atkinson MA.
    Diabetes; 2006 Jul; 55(7):1939-45. PubMed ID: 16804061
    [Abstract] [Full Text] [Related]

  • 5. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis.
    Beharry S, Ackerley C, Corey M, Kent G, Heng YM, Christensen H, Luk C, Yantiss RK, Nasser IA, Zaman M, Freedman SD, Durie PR.
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G839-48. PubMed ID: 17095751
    [Abstract] [Full Text] [Related]

  • 6. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.
    Naito Y, Takagi T, Uchiyama K, Kuroda M, Kokura S, Ichikawa H, Yanagisawa R, Inoue K, Takano H, Satoh M, Yoshida N, Okanoue T, Yoshikawa T.
    Int J Mol Med; 2004 Aug; 14(2):191-6. PubMed ID: 15254764
    [Abstract] [Full Text] [Related]

  • 7. CFTR dysfunction predisposes to fibrotic liver disease in a murine model.
    Martin CR, Zaman MM, Ketwaroo GA, Bhutta AQ, Coronel E, Popov Y, Schuppan D, Freedman SD.
    Am J Physiol Gastrointest Liver Physiol; 2012 Aug 15; 303(4):G474-81. PubMed ID: 22679000
    [Abstract] [Full Text] [Related]

  • 8. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis.
    Kinnman N, Lindblad A, Housset C, Buentke E, Scheynius A, Strandvik B, Hultcrantz R.
    Hepatology; 2000 Aug 15; 32(2):334-40. PubMed ID: 10915740
    [Abstract] [Full Text] [Related]

  • 9. Targeted inactivation of cystic fibrosis transmembrane conductance regulator chloride channel gene prevents ischemic preconditioning in isolated mouse heart.
    Chen H, Liu LL, Ye LL, McGuckin C, Tamowski S, Scowen P, Tian H, Murray K, Hatton WJ, Duan D.
    Circulation; 2004 Aug 10; 110(6):700-4. PubMed ID: 15289377
    [Abstract] [Full Text] [Related]

  • 10. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
    Tanaka T, Masuzaki H, Ebihara K, Ogawa Y, Yasue S, Yukioka H, Chusho H, Miyanaga F, Miyazawa T, Fujimoto M, Kusakabe T, Kobayashi N, Hayashi T, Hosoda K, Nakao K.
    Metabolism; 2005 Nov 10; 54(11):1490-8. PubMed ID: 16253638
    [Abstract] [Full Text] [Related]

  • 11. Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice.
    Bodewes FA, Wouthuyzen-Bakker M, Bijvelds MJ, Havinga R, de Jonge HR, Verkade HJ.
    Am J Physiol Gastrointest Liver Physiol; 2012 May 01; 302(9):G1035-42. PubMed ID: 22301109
    [Abstract] [Full Text] [Related]

  • 12. Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine.
    De Lisle RC, Meldi L, Flynn M, Jansson K.
    J Pediatr Gastroenterol Nutr; 2008 Oct 01; 47(4):406-16. PubMed ID: 18852632
    [Abstract] [Full Text] [Related]

  • 13. Prostacyclin-induced peroxisome proliferator-activated receptor-alpha translocation attenuates NF-kappaB and TNF-alpha activation after renal ischemia-reperfusion injury.
    Chen HH, Chen TW, Lin H.
    Am J Physiol Renal Physiol; 2009 Oct 01; 297(4):F1109-18. PubMed ID: 19640904
    [Abstract] [Full Text] [Related]

  • 14. Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney.
    Jouret F, Bernard A, Hermans C, Dom G, Terryn S, Leal T, Lebecque P, Cassiman JJ, Scholte BJ, de Jonge HR, Courtoy PJ, Devuyst O.
    J Am Soc Nephrol; 2007 Mar 01; 18(3):707-18. PubMed ID: 17287432
    [Abstract] [Full Text] [Related]

  • 15. Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice.
    Richardson TA, Morgan ET.
    J Pharmacol Exp Ther; 2005 Aug 01; 314(2):703-9. PubMed ID: 15860574
    [Abstract] [Full Text] [Related]

  • 16. Suppression of experimental colitis by intestinal mononuclear phagocytes.
    Qualls JE, Kaplan AM, van Rooijen N, Cohen DA.
    J Leukoc Biol; 2006 Oct 01; 80(4):802-15. PubMed ID: 16888083
    [Abstract] [Full Text] [Related]

  • 17. Abnormally up-regulated cystic fibrosis transmembrane conductance regulator expression and uterine fluid accumulation contribute to Chlamydia trachomatis-induced female infertility.
    He Q, Tsang LL, Ajonuma LC, Chan HC.
    Fertil Steril; 2010 May 15; 93(8):2608-14. PubMed ID: 20227074
    [Abstract] [Full Text] [Related]

  • 18. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
    Hays T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM.
    Carcinogenesis; 2005 Jan 15; 26(1):219-27. PubMed ID: 15447978
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
    de Gottardi A, Pazienza V, Pugnale P, Bruttin F, Rubbia-Brandt L, Juge-Aubry CE, Meier CA, Hadengue A, Negro F.
    Aliment Pharmacol Ther; 2006 Jan 01; 23(1):107-14. PubMed ID: 16393287
    [Abstract] [Full Text] [Related]

  • 20. Peroxisome proliferator-activated receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes.
    Reynders V, Loitsch S, Steinhauer C, Wagner T, Steinhilber D, Bargon J.
    Respir Res; 2006 Jul 30; 7(1):104. PubMed ID: 16875506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.